JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 8.78% |
| 4 | Healthcare | 7.93% |
| 5 | Communication Services | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
iShares MSCI Germany ETF
EWG
$1.68B
| $4.31M | ﹤0.01% |
101,482
-2,091
| -2% | -$86.6K |
|
3327
dLocal
DLO
$4.17B
| $4.31M | ﹤0.01% |
304,984
+31,584
| +12% | +$446K |
|
|
OTF
3328
Blue Owl Technology Finance Corp
OTF
$5.25B
| $4.31M | ﹤0.01% |
296,205
+241,468
| +441% | +$3.39M |
|
3329
Nu Skin
NUS
$234M
| $4.31M | ﹤0.01% |
447,624
-44,458
| -9% | -$460K |
|
3330
Preferred Bank
PFBC
$1.28B
| $4.3M | ﹤0.01% |
45,528
+2,052
| +5% | +$191K |
|
3331
CALL
SiteOne Landscape Supply
SITE
$4.3B
| $4.3M | ﹤0.01% |
+34,500
| New | +$4.37M |
|
3332
Ardelyx
ARDX
$1.05B
| $4.29M | ﹤0.01% |
736,190
-267,099
| -27% | -$1.49M |
|
3333
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.7B
| $4.29M | ﹤0.01% |
62,695
+14,470
| +30% | +$990K |
|
3334
First Trust Short Duration Managed Municipal ETF
FSMB
$628M
| $4.29M | ﹤0.01% |
214,080
-29,026
| -12% | -$582K |
|
3335
Erasca
ERAS
$6.43B
| $4.29M | ﹤0.01% |
1,153,090
-115,952
| -9% | -$326K |
|
3336
National Healthcare
NHC
$3.5B
| $4.29M | ﹤0.01% |
31,289
-23,921
| -43% | -$3.09M |
|
|
RERE
3337
ATRenew
RERE
$1.01B
| $4.29M | ﹤0.01% |
808,934
+436,577
| +117% | +$1.96M |
|
3338
Invesco S&P 100 Equal Weight ETF
EQWL
$2.8B
| $4.28M | ﹤0.01% |
36,244
+108
| +0.3% | +$12.6K |
|
3339
AAR Corp
AIR
$5.85B
| $4.28M | ﹤0.01% |
51,722
-39,798
| -43% | -$3.29M |
|
3340
Brookfield Renewable
BEPC
$6.59B
| $4.28M | ﹤0.01% |
111,684
-117,204
| -51% | -$4.72M |
|
3341
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.9B
| $4.27M | ﹤0.01% |
111,464
+584
| +0.5% | +$22.2K |
|
3342
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $4.27M | ﹤0.01% |
322,315
+113,311
| +54% | +$1.53M |
|
3343
Dimensional Global Real Estate ETF
DFGR
$3.85B
| $4.26M | ﹤0.01% |
161,252
-21,755
| -12% | -$587K |
|
3344
Taysha Gene Therapies
TSHA
$1.9B
| $4.26M | ﹤0.01% |
774,412
+478,168
| +161% | +$2.32M |
|
|
ADAM
3345
Adamas Trust
ADAM
$910M
| $4.26M | ﹤0.01% |
583,267
-58,714
| -9% | -$417K |
|
3346
PUT
Corning
GLW
$143B
| $4.26M | ﹤0.01% |
48,600
-14,100
| -22% | -$1.21M |
|
3347
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $4.25M | ﹤0.01% |
+30,000
| New | +$4.35M |
|
|
3348
PUT
Neurocrine Biosciences
NBIX
$15.5B
| $4.25M | ﹤0.01% |
+30,000
| New | +$4.35M |
|
3349
Coursera
COUR
$1.53B
| $4.25M | ﹤0.01% |
577,313
+359,010
| +164% | +$3.13M |
|
3350
Amphastar Pharmaceuticals
AMPH
$889M
| $4.25M | ﹤0.01% |
158,644
-94,588
| -37% | -$2.44M |
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $108B in Q4 2025, closing 563 positions and reducing 3,330 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.